十年首亏!中国中药净利暴跌2507%,黄金赛道失速或是“失血”主因

华夏时报网
Jan 31

2026年1月27日,中国中药发布业绩预警公告。预计2025年度将由盈转亏,亏损额介于3.5亿至5亿元。这家中药行业的“国家队”企业,净利润同比暴跌1785%至2507%,创下十年首亏记录。   中药配方颗粒作为公司的核心业务,占中国中药总营收的近一半,市场占有率高达53%。而随着2023年中药配方颗粒省际联盟集中带量采购的全面推行,这一曾经被视为“黄金赛道”的业务板块,其价格天花板被全面压缩,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10